CG Oncology (CGON) News Today $22.17 +0.47 (+2.18%) As of 02:46 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Analysts Set CG Oncology, Inc. (NASDAQ:CGON) PT at $57.70May 7 at 1:19 AM | americanbankingnews.comAvidity Partners Management LP Has $31.49 Million Stock Position in CG Oncology, Inc. (NASDAQ:CGON)Avidity Partners Management LP decreased its position in CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 33.7% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 1,097,800 shares of the company's stock after selling 558,200 shares during the quaMay 6 at 7:39 AM | marketbeat.comCG Oncology, Inc. (NASDAQ:CGON) Given Consensus Recommendation of "Buy" by AnalystsShares of CG Oncology, Inc. (NASDAQ:CGON - Get Free Report) have earned a consensus recommendation of "Buy" from the twelve research firms that are presently covering the firm, MarketBeat reports. One analyst has rated the stock with a hold recommendation, ten have given a buy recommendation and oMay 6 at 2:11 AM | marketbeat.comCG Oncology, Inc. (NASDAQ:CGON) Shares Purchased by Invesco Ltd.Invesco Ltd. grew its holdings in CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 75.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 27,069 shares of the company's stock after acquiring an additional 11,662 shares durMay 5 at 3:16 AM | marketbeat.comCG Oncology (NASDAQ:CGON) Coverage Initiated by Analysts at JPMorgan Chase & Co.JPMorgan Chase & Co. started coverage on CG Oncology in a research report on Friday. They issued an "overweight" rating and a $41.00 target price for the company.May 4 at 8:30 AM | marketbeat.comAlly Bridge Group NY LLC Sells 89,218 Shares of CG Oncology, Inc. (NASDAQ:CGON)Ally Bridge Group NY LLC lessened its holdings in shares of CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 33.9% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 174,048 shares of the company's stock after selling 89,218 shares during the period. CG OncMay 4 at 7:45 AM | marketbeat.comAcorn Capital Advisors LLC Buys New Shares in CG Oncology, Inc. (NASDAQ:CGON)Acorn Capital Advisors LLC purchased a new position in shares of CG Oncology, Inc. (NASDAQ:CGON - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 1,131,501 shares of the company's stock, valued at approximately $32,451,000. CG OncolMay 4 at 7:12 AM | marketbeat.comCG Oncology (CGON) Projected to Post Quarterly Earnings on ThursdayCG Oncology (NASDAQ:CGON) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-cg-oncology-inc-common-stock-stock/)May 3, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Has $27.11 Million Stake in CG Oncology, Inc. (NASDAQ:CGON)Price T Rowe Associates Inc. MD lifted its stake in shares of CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 59.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 945,194 shares of the company's stocMay 3, 2025 | marketbeat.comJP Morgan Initiates Coverage of CG Oncology (CGON) with Overweight RecommendationMay 3, 2025 | msn.com36,872 Shares in CG Oncology, Inc. (NASDAQ:CGON) Bought by Monashee Investment Management LLCMonashee Investment Management LLC acquired a new position in CG Oncology, Inc. (NASDAQ:CGON - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 36,872 shares of the company's stock, valuMay 2, 2025 | marketbeat.comBarclays PLC Acquires 10,737 Shares of CG Oncology, Inc. (NASDAQ:CGON)Barclays PLC increased its holdings in CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 11.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 101,257 shares of the company's stock after acquiMay 2, 2025 | marketbeat.comRoyal Bank of Canada Issues Positive Forecast for CG Oncology (NASDAQ:CGON) Stock PriceMay 2, 2025 | americanbankingnews.comCG Oncology (NASDAQ:CGON) Price Target Raised to $68.00Royal Bank of Canada upped their price objective on CG Oncology from $66.00 to $68.00 and gave the stock an "outperform" rating in a research report on Tuesday.May 1, 2025 | marketbeat.comAdage Capital Partners GP L.L.C. Sells 200,000 Shares of CG Oncology, Inc. (NASDAQ:CGON)Adage Capital Partners GP L.L.C. lessened its position in CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 50.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 200,000 shares of the company's stock after selling 200,000May 1, 2025 | marketbeat.comCG Oncology (NASDAQ:CGON) Shares Gap Up - Should You Buy?CG Oncology (NASDAQ:CGON) Shares Gap Up - Should You Buy?April 30, 2025 | marketbeat.comCG Oncology's (CGON) Overweight Rating Reiterated at Cantor FitzgeraldCantor Fitzgerald reaffirmed an "overweight" rating and issued a $75.00 price target on shares of CG Oncology in a research note on Monday.April 30, 2025 | marketbeat.comHC Wainwright Reaffirms Buy Rating for CG Oncology (NASDAQ:CGON)HC Wainwright reaffirmed a "buy" rating and issued a $75.00 price objective on shares of CG Oncology in a research note on Monday.April 30, 2025 | marketbeat.comForesite Capital Management VI LLC Takes $63.71 Million Position in CG Oncology, Inc. (NASDAQ:CGON)Foresite Capital Management VI LLC purchased a new position in shares of CG Oncology, Inc. (NASDAQ:CGON - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 2,22April 30, 2025 | marketbeat.comLeonard E. Post Sells 1,000 Shares of CG Oncology, Inc. (NASDAQ:CGON) StockApril 30, 2025 | insidertrades.comCantor Fitzgerald Reiterates Overweight Rating for CG Oncology (NASDAQ:CGON)April 30, 2025 | americanbankingnews.comCG Oncology Stock Price, Quotes and Forecasts | NASDAQ:CGON | BenzingaApril 29, 2025 | benzinga.comWhy CG Oncology, Inc. (CGON) Surged on MondayApril 29, 2025 | msn.comBuy Rating for CG Oncology, Inc. Driven by Cretostimogene’s Potential in Bladder Cancer Treatment Amid BCG ShortageApril 29, 2025 | tipranks.comCG Oncology Shares Climb on Bladder-Cancer Treatment ResultsApril 28, 2025 | marketwatch.comCG Oncology Soars On Its Johnson & Johnson-Rivaling Cancer DrugApril 28, 2025 | msn.comCG Oncology's Bladder Cancer Drug Impresses Investors - Here's WhyApril 28, 2025 | benzinga.comDecheng Capital LLC Grows Holdings in CG Oncology, Inc. (NASDAQ:CGON)Decheng Capital LLC raised its stake in CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 16.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 6,371,669 shares of the company's stock after acquiring an additional 892,859 shares during tApril 28, 2025 | marketbeat.comHead to Head Analysis: CG Oncology (CGON) and Its PeersApril 28, 2025 | americanbankingnews.comCG Oncology announces Phase 3 BOND-003 data presented at AUA meetingApril 28, 2025 | markets.businessinsider.comCG Oncology to hold a conference callApril 28, 2025 | markets.businessinsider.comCG Oncology (CGON) vs. The Competition Head to Head SurveyApril 28, 2025 | americanbankingnews.comBuy Rating for CG Oncology, Inc.: Promising Efficacy and Competitive Positioning in NMIBC TreatmentApril 27, 2025 | tipranks.comCG Oncology to Host Conference Call and Webcast on BOND-003 Data on Monday, April 28, 2025April 26, 2025 | seekingalpha.comCG Oncology Announces Best-in-Disease Durability Data in BOND-003 Cohort C and Promising Early Signal in Cohort P for Cretostimogene Grenadenorepvec at the American Urological Association Annual MeetingApril 26, 2025 | globenewswire.comXTX Topco Ltd Takes $573,000 Position in CG Oncology, Inc. (NASDAQ:CGON)XTX Topco Ltd purchased a new position in CG Oncology, Inc. (NASDAQ:CGON - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 19,996 shares of the company's stock, valued at approximately $573,000. Other heApril 22, 2025 | marketbeat.comCG Oncology, Inc. (NASDAQ:CGON) Shares Acquired by JPMorgan Chase & Co.JPMorgan Chase & Co. grew its stake in shares of CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 443.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 168,866 shares of the company's stock after purchasiApril 21, 2025 | marketbeat.comMarshall Wace LLP Has $41.82 Million Holdings in CG Oncology, Inc. (NASDAQ:CGON)Marshall Wace LLP increased its holdings in CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 18,836.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,458,072 shares of the company'sApril 20, 2025 | marketbeat.comGeode Capital Management LLC Has $33.18 Million Stock Position in CG Oncology, Inc. (NASDAQ:CGON)Geode Capital Management LLC lifted its stake in CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 7.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,156,670 shares of the company's stock after acquirApril 19, 2025 | marketbeat.comCG Oncology (NASDAQ:CGON) Now Covered by ScotiabankScotiabank began coverage on shares of CG Oncology in a research note on Wednesday. They issued a "sector perform" rating and a $23.00 price target for the company.April 18, 2025 | marketbeat.com224,580 Shares in CG Oncology, Inc. (NASDAQ:CGON) Acquired by Walleye Capital LLCWalleye Capital LLC bought a new stake in CG Oncology, Inc. (NASDAQ:CGON - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 224,580 shares of the company's stock, valued at approximately $6,441,000. WaApril 18, 2025 | marketbeat.comCG Oncology initiated with a Sector Perform at ScotiabankApril 18, 2025 | markets.businessinsider.comScotiabank Initiates Coverage of CG Oncology (CGON) with Sector Perform RecommendationApril 18, 2025 | msn.comAffinity Asset Advisors LLC Invests $2.87 Million in CG Oncology, Inc. (NASDAQ:CGON)Affinity Asset Advisors LLC purchased a new stake in CG Oncology, Inc. (NASDAQ:CGON - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 100,000 shares of the company's stock, valued at appApril 17, 2025 | marketbeat.comCenterBook Partners LP Sells 73,188 Shares of CG Oncology, Inc. (NASDAQ:CGON)CenterBook Partners LP cut its stake in CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 23.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 236,108 shares of the company's stock after selling 73,188 shares during tApril 11, 2025 | marketbeat.comCG Oncology, Inc. (NASDAQ:CGON) Receives Average Rating of "Buy" from AnalystsCG Oncology, Inc. (NASDAQ:CGON - Get Free Report) has received a consensus rating of "Buy" from the ten research firms that are presently covering the firm, Marketbeat.com reports. Nine equities research analysts have rated the stock with a buy recommendation and one has issued a strong buy recomApril 10, 2025 | marketbeat.comCG Oncology (NASDAQ:CGON) Sets New 52-Week Low - What's Next?CG Oncology (NASDAQ:CGON) Hits New 1-Year Low - Time to Sell?April 9, 2025 | marketbeat.comADAR1 Capital Management LLC Buys 72,646 Shares of CG Oncology, Inc. (NASDAQ:CGON)ADAR1 Capital Management LLC increased its position in CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 50.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 215,750 shares of the company's stock after acquiring an additionaApril 9, 2025 | marketbeat.comMassachusetts Financial Services Co. MA Sells 22,788 Shares of CG Oncology, Inc. (NASDAQ:CGON)Massachusetts Financial Services Co. MA lowered its stake in CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 8.1% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 257,157 shares of the company's stock after selling 22,788 shaApril 9, 2025 | marketbeat.comBuy Rating Affirmed for CG Oncology Amid Promising Trial Data and Market OpportunitiesApril 8, 2025 | tipranks.com Get CG Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for CGON and its competitors with MarketBeat's FREE daily newsletter. Email Address CGON Media Mentions By Week CGON Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CGON News Sentiment▼0.930.64▲Average Medical News Sentiment CGON News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CGON Articles This Week▼164▲CGON Articles Average Week Get CG Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for CGON and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Roivant Sciences News Today Revolution Medicines News Today Lantheus News Today BridgeBio Pharma News Today TG Therapeutics News Today Legend Biotech News Today Sarepta Therapeutics News Today Telix Pharmaceuticals Limited American Depositary Shares News Today ADMA Biologics News Today Blueprint Medicines News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CGON) was last updated on 5/7/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredYour Wealth is Being Erased – Save It Before It’s Gone ForeverWhat If America's Gold Reserves Are a Lie? For decades, the U.S. government has claimed to have thousands o...Hamilton Gold Group | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CG Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CG Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CGON Stock Free CGON Stock Alerts